市場調査レポート

商品コード

1786839

糖尿病性ケトアシドーシス（DKA）治療の世界市場、規模、シェア、動向、産業分析レポート：治療タイプ別、用途別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Diabetic Ketoacidosis Treatment Market Size, Share, Trends, & Industry Analysis Report By Treatment Type, By Application (Pediatric and Adults), By End User, and By Region - Market Forecast, 2025-2034

出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 635,502円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 785,032円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 934,562円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、糖尿病性ケトアシドーシス（DKA）治療市場規模は2034年までに12億9,208万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

糖尿病性ケトアシドーシス（DKA）治療は、1型糖尿病患者の急性糖尿病性緊急事態における代謝不均衡の是正に不可欠です。標準的な治療には、高血糖とアシドーシスを安定させるためのインスリン静注、輸液蘇生、電解質補充が含まれます。インスリンアナログ、持続グルコースモニタリングデバイス、リアルタイム電解質管理における進歩は、病院、ICU、外来治療環境における治療成績を向上させています。

糖尿病性ケトアシドーシス（DKA）治療市場の成長は、主に1型糖尿病の世界の有病率の上昇と、急性期医療環境におけるデジタルヘルスプラットフォームの採用増加によってもたらされます。さらに、外来救急インフラの拡大や支払者が支援する分散型治療モデルが、新興経済諸国や先進経済諸国での採用を加速しています。

糖尿病性ケトアシドーシス（DKA）治療市場レポートハイライト

治療タイプ別では、インスリン療法が2024年の市場を独占しました。これは、緊急のDKAプロトコルにおける迅速なグルコース減少のための第一選択薬として継続的に使用されているためです。

用途別では、成人市場が2024年の市場を独占しました。この背景には、成人集団におけるインスリン投与漏れ、併存疾患、糖尿病管理の遅れに関連した入院率の上昇があります。

エンドユーザー別では、病院セグメントが2024年に市場を席巻しました。これは、高度な診断、点滴療法、重症治療スタッフへのアクセスにより、重症で再発性のDKA症例を管理する包括的な能力があるためです。

北米は2024年の糖尿病性ケトアシドーシス（DKA）治療市場の大半を占め、CGMの普及、インスリンデリバリーシステムのデジタル化、標準化された治療プロトコルの遵守が市場のリーダーシップを支えています。

アジア太平洋地域は、1型糖尿病の罹患率の増加と緊急糖尿病治療への公的医療投資により、大きな市場シェアを占めています。

世界の主要市場プレーヤーには、Novo Nordisk A/S、Sanofi、Eli Lilly and Company、Becton, Dickinson and Company（BD）、Dexcom, Inc.、Medtronic plc、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、Insulet Corporation、Tandem Diabetes Care, Inc.、Ypsomed AG、Glenmark Pharmaceuticals Ltd.などが含まれます。

市場スナップショット
糖尿病性ケトアシドーシス（DKA）治療市場力学
- 促進要因と機会
  - 世界中で1型糖尿病の有病率が上昇
  - 急性期ケアにおけるデジタルヘルスプラットフォームの統合
- 抑制要因と課題
  - 急性期ケアインフラの高コスト負担
PESTEL分析
糖尿病性ケトアシドーシス（DKA）治療市場の動向
バリューチェーン分析

第5章世界の糖尿病性ケトアシドーシス（DKA）治療市場：治療タイプ別

主な調査結果
イントロダクション
インスリン療法
水分補給
電解質補給

第6章世界の糖尿病性ケトアシドーシス（DKA）治療市場：用途別

主な調査結果
イントロダクション
小児
成人

第7章世界の糖尿病性ケトアシドーシス（DKA）治療市場：エンドユーザー別

主な調査結果
イントロダクション
専門クリニック
外来診療センター
病院

第8章世界の糖尿病性ケトアシドーシス（DKA）治療市場：地域別

主な調査結果
イントロダクション
- 糖尿病性ケトアシドーシス（DKA）治療市場分析：地域別、2020年～2034年
北米
- 北米：治療タイプ別、2020～2034年
- 北米：用途別、2020～2034年
- 北米：エンドユーザー別、2020～2034年
- 米国
- カナダ
欧州
- 欧州：治療タイプ別、2020～2034年
- 欧州：用途別、2020～2034年
- 欧州：エンドユーザー別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋地域
- アジア太平洋地域：治療タイプ別、2020年～2034年
- アジア太平洋地域：用途別、2020～2034年
- アジア太平洋地域：エンドユーザー別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ
- 中東・アフリカ：治療タイプ別、2020～2034年
- 中東・アフリカ：用途別、2020～2034年
- 中東・アフリカ：エンドユーザー別、2020～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：治療タイプ別、2020～2034年
- ラテンアメリカ：用途別、2020～2034年
- ラテンアメリカ：エンドユーザー別、2020～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Abbott Laboratories
Becton, Dickinson and Company（BD）
Dexcom, Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Glenmark Pharmaceuticals Ltd
Insulet Corporation
Medtronic plc
Novo Nordisk A/S
Sanofi
Tandem Diabetes Care, Inc.
Ypsomed AG

図表

List of Tables:

Table 1 Global Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 2 Global Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 3 Global Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 4 North America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 5 North America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 6 North America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 7 U.S.: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 8 U.S.: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 9 U.S.: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 10 Canada: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 11 Canada: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 12 Canada: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 13 Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 14 Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 15 Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 16 UK: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 17 UK: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 18 UK: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 19 France: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 20 France: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 21 France: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 22 Germany: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 23 Germany: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 24 Germany: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 25 Italy: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 26 Italy: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 27 Italy: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 28 Spain: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 29 Spain: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 30 Spain: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 31 Netherlands: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 32 Netherlands: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 33 Netherlands: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 34 Russia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 35 Russia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 36 Russia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 37 Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 38 Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 39 Rest of Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 40 Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 41 Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 42 Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 43 China: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 44 China: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 45 China: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 46 India: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 47 India: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 48 India: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 49 Malaysia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 50 Malaysia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 51 Malaysia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 52 Japan: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 53 Japan: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 54 Japan: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 55 Indonesia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 56 Indonesia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 57 Indonesia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 58 South Korea: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 59 South Korea: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 60 South Korea: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 61 Australia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 62 Australia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 63 Australia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 64 Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 65 Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 66 Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 67 Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 68 Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 69 Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 70 Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 71 Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 72 Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 73 UAE: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 74 UAE: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 75 UAE: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 76 Israel: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 77 Israel: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 78 Israel: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 79 South Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 80 South Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 81 South Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 82 Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 83 Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 84 Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 85 Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 86 Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 87 Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 88 Mexico: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 89 Mexico: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 90 Mexico: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 91 Brazil: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 92 Brazil: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 93 Brazil: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 94 Argentina: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 95 Argentina: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 96 Argentina: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
Table 97 Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
Table 98 Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
Table 99 Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Diabetic Ketoacidosis Treatment Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Treatment Type
Figure 7. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2024 & 2034 (USD Million)
Figure 8. Market by Application
Figure 9. Global Diabetic Ketoacidosis Treatment Market, by Application, 2024 & 2034 (USD Million)
Figure 10. Market by End User
Figure 11. Global Diabetic Ketoacidosis Treatment Market, by End User, 2024 & 2034 (USD Million)

Product Code: PM6065

The diabetic ketoacidosis treatment market size is expected to reach USD 1,292.08 Million by 2034, according to a new study by Polaris Market Research. The report "Diabetic Ketoacidosis Treatment Market Share, Size, Trends, Industry Analysis Report: By Treatment Type, By Application (Pediatric and Adults), By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetic ketoacidosis treatment is essential for correcting metabolic imbalance during acute diabetic emergencies in type 1 diabetes patients. Standard care includes intravenous insulin, fluid resuscitation and electrolyte replacement to stabilize hyperglycemia and acidosis. Advancements in insulin analogs, continuous glucose monitoring device and real-time electrolyte management are enhancing treatment outcomes across hospitals, ICUs and ambulatory care settings.

The growth of the diabetic ketoacidosis treatment market is primarily driven by the rising global prevalence of type 1 diabetes and increased adoption of digital health platforms in acute care settings. Additionally, the expansion of outpatient emergency infrastructure and payer-supported decentralized treatment models are accelerating adoption across developing and developed economies.

Diabetic Ketoacidosis Treatment Market Report Highlights

Based on treatment type, the insulin therapy dominated the market in 2024, owing to its continued use as the first-line intervention for rapid glucose reduction in emergency DKA protocols.

In terms of application, the adult segment dominated the market in 2024. This is driven by higher hospitalization rates linked to insulin omission, comorbidities, and delayed diabetes management in adult populations.

In terms of end user, the hospital segment dominated the market in 2024, owing to its comprehensive capacity to manage severe and recurrent DKA cases with access to advanced diagnostics, IV therapies and critical care staff.

North America accounted for the majority share of the global diabetic ketoacidosis treatment market in 2024, fueled by widespread CGM adoption, digital insulin delivery systems and adherence to standardized treatment protocols support market leadership.

Asia Pacific held significant market share, fueled by growing incidence of type 1 diabetes and public healthcare investments in emergency diabetic care.

A few global key market players include Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company (BD), Dexcom, Inc., Medtronic plc, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Insulet Corporation, Tandem Diabetes Care, Inc., Ypsomed AG, and Glenmark Pharmaceuticals Ltd.

Polaris Market Research has segmented the market report on the basis of treatment type, application, end user, and region:

By Treatment Type Outlook (Revenue, USD Million, 2020-2034)

Insulin Therapy

Fluid Replacement

Electrolyte Replacement

By Application Outlook (Revenue, USD Million, 2020-2034)

Pediatric

Adults

By End User Outlook (Revenue, USD Million, 2020-2034)

Specialty Clinics

Ambulatory Care Center

Hospitals

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Diabetic Ketoacidosis Treatment Market Insights

4.1. Diabetic Ketoacidosis Treatment Market - Market Snapshot
4.2. Diabetic Ketoacidosis Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Type 1 Diabetes Worldwide
  - 4.2.1.2. Integration of Digital Health Platforms in Acute Care Settings
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost Burden of Acute Care Infrastructure
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Diabetic Ketoacidosis Treatment Market Trends
4.6. Value Chain Analysis

5. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
5.3. Insulin Therapy
- 5.3.1. Global Diabetic Ketoacidosis Treatment Market, by Insulin Therapy, by Region, 2020-2034 (USD Million)
5.4. Fluid Replacement
- 5.4.1. Global Diabetic Ketoacidosis Treatment Market, by Fluid Replacement, by Region, 2020-2034 (USD Million)
5.5. Electrolyte Replacement
- 5.5.1. Global Diabetic Ketoacidosis Treatment Market, by Electrolyte Replacement, by Region, 2020-2034 (USD Million)

6. Global Diabetic Ketoacidosis Treatment Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
6.3. Pediatric
- 6.3.1. Global Diabetic Ketoacidosis Treatment Market, by Pediatric, by Region, 2020-2034 (USD Million)
6.4. Adults
- 6.4.1. Global Diabetic Ketoacidosis Treatment Market, by Adults, by Region, 2020-2034 (USD Million)

7. Global Diabetic Ketoacidosis Treatment Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
7.3. Specialty Clinics
- 7.3.1. Global Diabetic Ketoacidosis Treatment Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
7.4. Ambulatory Care Center
- 7.4.1. Global Diabetic Ketoacidosis Treatment Market, by Ambulatory Care Center, by Region, 2020-2034 (USD Million)
7.5. Hospitals
- 7.5.1. Global Diabetic Ketoacidosis Treatment Market, by Hospitals, by Region, 2020-2034 (USD Million)

8. Global Diabetic Ketoacidosis Treatment Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Diabetic Ketoacidosis Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Diabetic Ketoacidosis Treatment Market - North America
- 8.3.1. North America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
- 8.3.2. North America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.3.4. Diabetic Ketoacidosis Treatment Market - U.S.
  - 8.3.4.1. U.S.: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.3.5. Diabetic Ketoacidosis Treatment Market - Canada
  - 8.3.5.1. Canada: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
8.4. Diabetic Ketoacidosis Treatment Market - Europe
- 8.4.1. Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.4. Diabetic Ketoacidosis Treatment Market - UK
  - 8.4.4.1. UK: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.5. Diabetic Ketoacidosis Treatment Market - France
  - 8.4.5.1. France: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.3. France: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.6. Diabetic Ketoacidosis Treatment Market - Germany
  - 8.4.6.1. Germany: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.7. Diabetic Ketoacidosis Treatment Market - Italy
  - 8.4.7.1. Italy: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.8. Diabetic Ketoacidosis Treatment Market - Spain
  - 8.4.8.1. Spain: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.9. Diabetic Ketoacidosis Treatment Market - Netherlands
  - 8.4.9.1. Netherlands: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.10. Diabetic Ketoacidosis Treatment Market - Russia
  - 8.4.10.1. Russia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.4.11. Diabetic Ketoacidosis Treatment Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
8.5. Diabetic Ketoacidosis Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.4. Diabetic Ketoacidosis Treatment Market - China
  - 8.5.4.1. China: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.3. China: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.5. Diabetic Ketoacidosis Treatment Market - India
  - 8.5.5.1. India: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.3. India: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.6. Diabetic Ketoacidosis Treatment Market - Malaysia
  - 8.5.6.1. Malaysia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.7. Diabetic Ketoacidosis Treatment Market - Japan
  - 8.5.7.1. Japan: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.8. Diabetic Ketoacidosis Treatment Market - Indonesia
  - 8.5.8.1. Indonesia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.9. Diabetic Ketoacidosis Treatment Market - South Korea
  - 8.5.9.1. South Korea: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.10. Diabetic Ketoacidosis Treatment Market - Australia
  - 8.5.10.1. Australia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.5.11. Diabetic Ketoacidosis Treatment Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
8.6. Diabetic Ketoacidosis Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.6.4. Diabetic Ketoacidosis Treatment Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.6.5. Diabetic Ketoacidosis Treatment Market - UAE
  - 8.6.5.1. UAE: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.6.6. Diabetic Ketoacidosis Treatment Market - Israel
  - 8.6.6.1. Israel: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.6.7. Diabetic Ketoacidosis Treatment Market - South Africa
  - 8.6.7.1. South Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.6.8. Diabetic Ketoacidosis Treatment Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
8.7. Diabetic Ketoacidosis Treatment Market - Latin America
- 8.7.1. Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.7.4. Diabetic Ketoacidosis Treatment Market - Mexico
  - 8.7.4.1. Mexico: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.7.5. Diabetic Ketoacidosis Treatment Market - Brazil
  - 8.7.5.1. Brazil: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.7.6. Diabetic Ketoacidosis Treatment Market - Argentina
  - 8.7.6.1. Argentina: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
- 8.7.7. Diabetic Ketoacidosis Treatment Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Becton, Dickinson and Company (BD)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Dexcom, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Eli Lilly and Company
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. F. Hoffmann-La Roche Ltd
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Glenmark Pharmaceuticals Ltd
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Insulet Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Medtronic plc
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Novo Nordisk A/S
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Sanofi
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Tandem Diabetes Care, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Ypsomed AG
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development

糖尿病性ケトアシドーシス（DKA）治療の世界市場、規模、シェア、動向、産業分析レポート：治療タイプ別、用途別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Diabetic Ketoacidosis Treatment Market Size, Share, Trends, & Industry Analysis Report By Treatment Type, By Application (Pediatric and Adults), By End User, and By Region - Market Forecast, 2025-2034

糖尿病性ケトアシドーシス（DKA）治療市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の糖尿病性ケトアシドーシス（DKA）治療市場の洞察

第5章世界の糖尿病性ケトアシドーシス（DKA）治療市場：治療タイプ別

第6章世界の糖尿病性ケトアシドーシス（DKA）治療市場：用途別

第7章世界の糖尿病性ケトアシドーシス（DKA）治療市場：エンドユーザー別

第8章世界の糖尿病性ケトアシドーシス（DKA）治療市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Diabetic Ketoacidosis Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Diabetic Ketoacidosis Treatment Market Insights

5. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type

6. Global Diabetic Ketoacidosis Treatment Market, by Application

7. Global Diabetic Ketoacidosis Treatment Market, by End User

8. Global Diabetic Ketoacidosis Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

糖尿病性ケトアシドーシス（DKA）治療の世界市場、規模、シェア、動向、産業分析レポート：治療タイプ別、用途別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Diabetic Ketoacidosis Treatment Market Size, Share, Trends, & Industry Analysis Report By Treatment Type, By Application (Pediatric and Adults), By End User, and By Region - Market Forecast, 2025-2034

糖尿病性ケトアシドーシス（DKA）治療市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の糖尿病性ケトアシドーシス（DKA）治療市場の洞察

第5章 世界の糖尿病性ケトアシドーシス（DKA）治療市場：治療タイプ別

第6章 世界の糖尿病性ケトアシドーシス（DKA）治療市場：用途別

第7章 世界の糖尿病性ケトアシドーシス（DKA）治療市場：エンドユーザー別

第8章 世界の糖尿病性ケトアシドーシス（DKA）治療市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Diabetic Ketoacidosis Treatment Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Diabetic Ketoacidosis Treatment Market Insights

5. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type

6. Global Diabetic Ketoacidosis Treatment Market, by Application

7. Global Diabetic Ketoacidosis Treatment Market, by End User

8. Global Diabetic Ketoacidosis Treatment Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の糖尿病性ケトアシドーシス（DKA）治療市場の洞察

第5章世界の糖尿病性ケトアシドーシス（DKA）治療市場：治療タイプ別

第6章世界の糖尿病性ケトアシドーシス（DKA）治療市場：用途別

第7章世界の糖尿病性ケトアシドーシス（DKA）治療市場：エンドユーザー別

第8章世界の糖尿病性ケトアシドーシス（DKA）治療市場：地域別

第9章競合情勢

第10章企業プロファイル